| Usgena |
Human |
ustekinumab |
ustekinumab |
EMEA/H/C/006667 |
Stada Arzneimittel AG |
2025/11/17
|
Authorised |
| Usrenty |
Human |
ustekinumab |
ustekinumab |
EMEA/H/C/006794 |
Biosimilar Collaborations Ireland Limited |
2025/09/17
|
Authorised |
| Usymro |
Human |
ustekinumab |
ustekinumab |
EMEA/H/C/006467 |
Gedeon Richter Plc. |
2025/08/14
|
Authorised |
| Qoyvolma |
Human |
ustekinumab |
ustekinumab |
EMEA/H/C/006649 |
Celltrion Healthcare Hungary Kft. |
2025/06/02
|
Authorised |
| Yesintek |
Human |
ustekinumab |
ustekinumab |
EMEA/H/C/006444 |
Biosimilar Collaborations Ireland Limited |
2025/02/14
|
Authorised |
| Absimky |
Human |
ustekinumab |
ustekinumab |
EMEA/H/C/006585 |
Accord Healthcare S.L.U. |
2024/12/12
|
Withdrawn |
| Imuldosa |
Human |
ustekinumab |
ustekinumab |
EMEA/H/C/006221 |
Accord Healthcare S.L.U. |
2024/12/12
|
Authorised |
| Otulfi |
Human |
ustekinumab |
ustekinumab |
EMEA/H/C/006544 |
Fresenius Kabi Deutschland GmbH |
2024/09/25
|
Authorised |
| Fymskina |
Human |
ustekinumab |
ustekinumab |
EMEA/H/C/005805 |
Formycon AG |
2024/09/25
|
Authorised |
| Eksunbi |
Human |
ustekinumab |
ustekinumab |
EMEA/H/C/006448 |
Samsung Bioepis NL B.V. |
2024/09/12
|
Withdrawn |
| Steqeyma |
Human |
ustekinumab |
ustekinumab |
EMEA/H/C/005918 |
Celltrion Healthcare Hungary Kft. |
2024/08/22
|
Authorised |
| Wezenla |
Human |
ustekinumab |
ustekinumab |
EMEA/H/C/006132 |
Amgen Technology (Ireland) UC |
2024/06/20
|
Authorised |
| Pyzchiva |
Human |
ustekinumab |
ustekinumab |
EMEA/H/C/006183 |
Samsung Bioepis NL B.V. |
2024/04/19
|
Authorised |
| Uzpruvo |
Human |
ustekinumab |
ustekinumab |
EMEA/H/C/006101 |
Stada Arzneimittel AG |
2024/01/05
|
Authorised |
| Stelara |
Human |
ustekinumab |
ustekinumab |
EMEA/H/C/000958 |
Janssen-Cilag International NV |
2009/01/15
|
Authorised |
| Upstelda |
Human |
ustekinumab |
ustekinumab |
EMEA/H/C/006415 |
Amgen Technology (Ireland) UC |
|
Application withdrawn |